| Synonyms: | |
| Status: | Approved (1960) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N01AF01 |
| UNII: | E5B8ND5IPE |
| InChI Key | NZXKDOXHBHYTKP-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C14H18N2O3 |
| Molecular Weight | 262.31 |
| AlogP | 1.31 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 66.48 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 19.0 |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Depression | Early Phase 1 | ClinicalTrials |
| Bipolar Disorder; Depression; Depressive Disorder | Phase 4 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 151-83-7 |
| ChEBI | 102216 |
| ChEMBL | CHEMBL7413 |
| DrugBank | DB00474 |
| DrugCentral | 1748 |
| EPA CompTox | DTXSID1023287 |
| FDA SRS | E5B8ND5IPE |
| Human Metabolome Database | HMDB0014617 |
| Guide to Pharmacology | 7233 |
| KEGG | C07844 |
| PharmGKB | PA164784030 |
| PubChem | 9034 |
| SureChEMBL | SCHEMBL80729 |